Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 136 AL 150

Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues

Ittner LM, Klugmann M, Ke YD.

Br J Pharmacol. 2019 Sep;176(18):3649-3665. doi: 10.1111/bph.14637. Epub 2019 Apr 23.

Lifestyle multidomain intervention, omega-3 supplementation, or both for reducing the risk of developing clinically relevant depressive symptoms in older adults with memory complaints? Secondary analysis from the MAPT trial

Maltais M, de Souto Barreto P, Pothier K, Cantet C, Andrieu S, Rolland Y, Vellas B; MAPT/DSA Study Group.

Exp Gerontol. 2019 Jun;120:28-34. doi: 10.1016/j.exger.2019.02.010. Epub 2019 Feb 26.

Natural barrigenol-like triterpenoids: A comprehensive review of their contributions to medicinal chemistry

Zhang X, Zhang S, Yang Y, Wang D, Gao H.

Phytochemistry. 2019 May;161:41-74. doi: 10.1016/j.phytochem.2019.01.017. Epub 2019 Feb 26.

Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease

Mezeiova E, Chalupova K, Nepovimova E, Gorecki L, Prchal L, Malinak D, Kuca K, Soukup O, Korabecny J.

Curr Alzheimer Res. 2019;16(9):772-800. doi: 10.2174/1567205016666190228122956.

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier JG, Harold D, Fitzpatrick AL, Valladares O, Moutet ML, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Del Zompo M, Fox NC, Choi SH, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, et al.

Nat Genet. 2019 Mar;51(3):414-430. doi: 10.1038/s41588-019-0358-2. Epub 2019 Feb 28.

Liraglutide and its Neuroprotective Properties-Focus on Possible Biochemical Mechanisms in Alzheimer's Disease and Cerebral Ischemic Events

Wiciński M, Socha M, Malinowski B, Wódkiewicz E, Walczak M, Górski K, Słupski M, Pawlak-Osińska K.

Int J Mol Sci. 2019 Feb 28;20(5):1050. doi: 10.3390/ijms20051050.

Pharmacological Interventions to Attenuate Alzheimer's Disease Progression: The Story So Far

Bazzari FH, Abdallah DM, El-Abhar HS.

Curr Alzheimer Res. 2019;16(3):261-277. doi: 10.2174/1567205016666190301111120.

A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment

Das B, Yan R.

CNS Drugs. 2019 Mar;33(3):251-263. doi: 10.1007/s40263-019-00613-7.

Measuring knowledge of Alzheimer's: development and psychometric testing of the UJA Alzheimer's Care Scale

Parra-Anguita L, Sánchez-García I, Del Pino-Casado R, Pancorbo-Hidalgo PL.

BMC Geriatr. 2019 Mar 4;19(1):63. doi: 10.1186/s12877-019-1086-2.

Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer's Disease

Ganeshpurkar A, Swetha R, Kumar D, Gangaram GP, Singh R, Gutti G, Jana S, Kumar D, Kumar A, Singh SK.

Curr Top Med Chem. 2019;19(7):501-533. doi: 10.2174/1568026619666190304153353.

Screaming behaviour in response to electroconvulsive treatment: psychogeriatric note on a patient with Alzheimer's disease

Johari N, Glue P, Barak Y.

Psychogeriatrics. 2019 Nov;19(6):626-627. doi: 10.1111/psyg.12443. Epub 2019 Mar 5.

Menopausal hormone therapy and cognition

Maki PM, Girard LM, Manson JE.

BMJ. 2019 Mar 6;364:l877. doi: 10.1136/bmj.l877.

Therapeutic Potential of Glucagon-Like Peptide-1 Cleavage Product for Alzheimer's Disease

Day SM, Ma T.

Neurosci Bull. 2019 Oct;35(5):934-936. doi: 10.1007/s12264-019-00355-y. Epub 2019 Mar 7.

The impact of curcumin and its modified formulations on Alzheimer's disease

Farkhondeh T, Samarghandian S, Pourbagher-Shahri AM, Sedaghat M.

J Cell Physiol. 2019 Aug;234(10):16953-16965. doi: 10.1002/jcp.28411. Epub 2019 Mar 7.

Ca(2+) homeostasis dysregulation in Alzheimer's disease: a focus on plasma membrane and cell organelles

Wang X, Zheng W.

FASEB J. 2019 Jun;33(6):6697-6712. doi: 10.1096/fj.201801751R. Epub 2019 Mar 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias